Swine Vaccines Market: Current Analysis and Forecast (2022-2028)
Emphasis on Product Type (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines); Type (Swine Influenza, Classical Swine Fever, Porcine Parvovirus, Porcine Circovirus Type 2, and M.Hyo); and Region/Country
The global swine vaccines market was valued at USD 1.5 billion in 2021 and expected to grow at a significant rate of around 5% during the forecast period 2022-2028. Swine vaccines are vaccines that are specifically designed to prevent or control diseases in pigs. These vaccines contain either live, attenuated, or inactivated forms of pathogens that can cause diseases in pigs, such as influenza, porcine reproductive and respiratory syndrome (PRRS), and porcine circovirus type 2 (PCV2). The swine vaccine market is expected to grow in the coming years due to the increasing demand for pork, the growing prevalence of swine diseases, and the development of advanced vaccine technologies.
The increasing swine disease outbreaks and zoonotic disease, together with the widespread use of antibiotic-free disease prevention techniques, are some of the major reasons driving the market’s expansion. Porcine reproductive and respiratory syndrome (PRRS) and swine influenza continue to be extremely common among swine herds in Asia, Europe, and America, causing significant economic damage. Hence, swine producers are widely employing biosecurity procedures and vaccination techniques to reduce the impact. For instance, the OIE (Office International des Epizooties), reports that between 2016 and 2020 there were 9,928 outbreaks of African swine fever in Asian swine herds, followed by 4,721 occurrences in Europe.
Merck & Co., Inc.; Ceva; Zoetis; Boehringer Ingelheim International GmbH; Elanco; Indian Immunologicals Ltd.; Biogénesis Bagó; Phibro Animal Health Corporation; KM Biologics; and HIPRA, S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst product type, inactivated vaccines category to witness robust CAGR during the forecast period.”
Based on product type, the market is segmented into attenuated live vaccines, inactivated vaccines, subunit vaccines, DNA vaccines, and recombinant vaccines. The inactivated vaccines category to witness higher CAGR during the forecast period. This is mainly due to the use of inactivated vaccines in swine production is driven by the need to protect the health of the animals, improve productivity, comply with regulatory requirements, and meet consumer demands. As technology continues to advance, we can expect to see continued growth in the use of inactivated vaccines in swine production.
“Amongst type, the swine influenza held a significant share in the market in 2021.”
On the basis of type, the market is categorized into swine influenza, classical swine fever, porcine parvovirus, porcine circovirus type 2, and m.hyo. Among these, swine influenza held a significant share of the market in 2021. This is mainly due to reducing the risk of transmission of the virus to humans, complying with regulatory requirements, meeting consumer demands, and taking advantage of advancements in vaccine technology. As the risks associated with swine influenza continue to be recognized, can expect to see continued growth in the use of swine influenza vaccines in swine vaccine production.
Swine Vaccines Market Report Coverage
“North America to hold a significant share in the market”
For a better understanding of the market adoption of the swine vaccines industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to several factors, including the rising demand for animal protein, the increasing prevalence of swine diseases, and the need to improve animal health and productivity, the demand for swine vaccines is expected to continue to grow. Advances in vaccine technology are also expected to further drive growth in the market, making it an exciting time for the swine vaccines industry in North America. For instance, in February 2021, Algenex SL and Virbac proclaimed that they have entered an international licensing agreement for the development and commercialization of a CrisBio-based vaccine in a key swine indication.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global swine vaccines market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Swine Vaccines Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global swine vaccines market were the three major steps undertaken to create and analyze the adoption of the swine vaccines market in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global swine vaccines market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the swine vaccines market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the swine vaccines market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product type and type. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the Swine Vaccines Market. Further, we conducted factor analysis using dependent and independent variables such as various product type and types of swine vaccines market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the swine vaccines market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global swine vaccines market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the swine vaccines market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global swine vaccines market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global swine vaccines market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product type and type in the global swine vaccines market.
The main objective of the Global Swine Vaccines Market Study
The current & future market trends of the global swine vaccines market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the swine vaccines market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of product type and type.
- Define and analysis of the regulatory framework for the swine vaccines market
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the swine vaccines market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
- Company profiles of the swine vaccines market and the growth strategies adopted by the market players to sustain in the fast-growing market.
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
